Showing 1 - 15 results of 15 for search 'Qilong Jiang', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
Use of Novel Polyurethane Microspheres in a Curcumin Delivery System by Yongmei Hu, Qingshan Li, Wei Hong, Guangzhong Xing, Qilong Jiang, Wenfeng Lv
Published 2014-01-01
Article -
7
-
8
-
9
-
10
-
11
Three-dimensional printed cast assisted screw fixation of calcaneal fractures: a prospective study by Qizhi Song, Tao Li, Huan Xia, Yan Li, Chengbin Feng, Yajun Lin, Huahong Wang, Jinbiao Hu, Qilong Jiang
Published 2023-10-01
Article -
12
Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series by Jie Song, Haiyan Wang, Xiao Huan, Qilong Jiang, Zongtai Wu, Chong Yan, Jianying Xi, Chongbo Zhao, Huiyu Feng, Sushan Luo
Published 2024-07-01
Article -
13
Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota by Senhui Weng, Linwen Huang, Bingxing Cai, Long He, Shuting Wen, Jinghao Li, Zhuotai Zhong, Haiyan Zhang, Chongyang Huang, Yunying Yang, Qilong Jiang, Fengbin Liu
Published 2023-08-01
Article -
14
Efgartigimod for generalized myasthenia gravis: A multicenter real‐world cohort study in China by Sushan Luo, Qilong Jiang, Wenshuang Zeng, Qinzhou Wang, Zhangyu Zou, Yanyan Yu, Daojun Hong, Quantao Zeng, Song Tan, Zhouao Zhang, Yong Zhang, Xiuming Guo, Jing Chen, Zhongyan Zhao, Shixiong Huang, Jianquan Shi, Ying Chen, Lei Du, Chong Yan, Jianying Xi, Jie Song, Chongbo Zhao, the Chinese Myasthenia Gravis Collaborating Group (CMGCG)
Published 2024-08-01
Article -
15
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes by Lei Jin, Zhangyu Zou, Qinzhou Wang, Wenshuang Zeng, Qilong Jiang, Jing Chen, Jianquan Shi, Yanyan Yu, Daojun Hong, Quantao Zeng, Song Tan, Yaoxian Yue, Zhouao Zhang, Yong Zhang, Xiuming Guo, Lei Du, Zhongyan Zhao, Shixiong Huang, Ying Chen, Zongtai Wu, Chong Yan, Jianying Xi, Jie Song, Sushan Luo, Chongbo Zhao
Published 2025-02-01
Article